Picture of Takeda Pharmaceutical Co logo

TAK Takeda Pharmaceutical Co News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapSuper Stock

REG - Morgan Stanley Takeda Pharma.Co.Ltd - Form 8.5 (EPT/NON-RI) - TAKEDA PHARMACEUTICAL





 




RNS Number : 6477W
Morgan Stanley
02 August 2018
 

 

FORM 8.5 (EPT/NON-RI)

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

1.         KEY INFORMATION

 

(a) Name of exempt principal trader:

Morgan Stanley MUFG Securities Co., Ltd.

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

     Use a separate form for each offeror/offeree

Takeda Pharmaceutical Company Limited

(c) Name of the party to the offer with which exempt principal trader is connected:

Shire plc

(d) Date position held/dealing undertaken:

     For an opening position disclosure, state the latest practicable date prior to the disclosure

01 AUGUST 2018

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

     If it is a cash offer or possible cash offer, state "N/A"

YES - Shire plc

 

2.         POSITIONS OF THE EXEMPT PRINCIPAL TRADER                            

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

 

Class of relevant security:

 

Ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

2,448,779

0.31

10,237,684

1.31

(2) Cash-settled derivatives:

 

10,019,934

1.28

2,106,800

0.27

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00

0

0.00

 

     TOTAL:

12,468,713

1.59

12,344,484

1.58

 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b)        Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3.         DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a)        Purchases and sales

 

Class of relevant security

 Purchases/sales

 Total   number of securities

 Highest price per unit paid/received

 Lowest price per unit paid/received

 Ordinary

 PURCHASES

 1,088,554

 4,844.0606 JPY

 4,629.7157 JPY

 Ordinary

 SALES

 1,483,768

 4,845.0000 JPY

 4,629.7157 JPY

 

 (b)       Cash-settled derivative transactions

 

Class of relevant security

 Product description

            e.g. CFD

 Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

 Number of reference securities

 Price per unit

Ordinary

CFD

LONG

300

4837.0000 JPY

Ordinary

CFD

SHORT

700

4771.7142 JPY

Ordinary

CFD

SHORT

19100

4797.2707 JPY

Ordinary

CFD

SHORT

51900

4790.6551 JPY

Ordinary

CFD

LONG

3300

4827.0303 JPY

Ordinary

CFD

LONG

9700

4802.2989 JPY

Ordinary

CFD

SHORT

5400

4764.1481 JPY

Ordinary

CFD

SHORT

400

4768.0000 JPY

Ordinary

CFD

LONG

400

4838.0000 JPY

Ordinary

CFD

SHORT

4100

4839.5609 JPY

Ordinary

CFD

LONG

2700

4844.0000 JPY

Ordinary

CFD

SHORT

2800

4844.0000 JPY

Ordinary

CFD

SHORT

6800

4844.0000 JPY

Ordinary

CFD

SHORT

800

4778.0000 JPY

Ordinary

CFD

LONG

400

4808.0000 JPY

Ordinary

CFD

SHORT

1300

4768.0000 JPY

Ordinary

CFD

LONG

2900

4790.1724 JPY

Ordinary

CFD

LONG

1600

4835.5625 JPY

Ordinary

CFD

SHORT

3300

4773.1115 JPY

Ordinary

CFD

SHORT

5900

4804.4947 JPY

Ordinary

CFD

LONG

20000

4837.7450 JPY

Ordinary

CFD

LONG

100

4780.0000 JPY

Ordinary

CFD

SHORT

1300

4768.0000 JPY

Ordinary

CFD

SHORT

6700

4844.0000 JPY

Ordinary

CFD

LONG

22500

4839.5306 JPY

Ordinary

CFD

SHORT

2700

4844.0000 JPY

Ordinary

CFD

LONG

1900

4836.5789 JPY

Ordinary

CFD

SHORT

1500

4844.0000 JPY

Ordinary

CFD

SHORT

100

4773.0000 JPY

Ordinary

CFD

LONG

100

4844.0000 JPY

Ordinary

CFD

LONG

100

4773.0000 JPY

Ordinary

CFD

SHORT

4100

4781.1707 JPY

Ordinary

CFD

LONG

900

4844.0000 JPY

Ordinary

CFD

SHORT

900

4844.0000 JPY

Ordinary

CFD

SHORT

1000

4844.0000 JPY

Ordinary

CFD

LONG

900

4844.0000 JPY

Ordinary

CFD

LONG

1000

4748.0000 JPY

Ordinary

CFD

LONG

2300

4794.0000 JPY

Ordinary

CFD

SHORT

300

4785.0000 JPY

Ordinary

CFD

LONG

500

4794.0000 JPY

Ordinary

CFD

SHORT

500

4785.0000 JPY

Ordinary

CFD

LONG

410960

4788.7172 JPY

Ordinary

CFD

SHORT

200

4775.0000 JPY

Ordinary

CFD

SHORT

6400

4748.2950 JPY

Ordinary

CFD

SHORT

3600

4748.2950 JPY

Ordinary

CFD

LONG

3200

4675.0000 JPY

Ordinary

CFD

SHORT

400

4730.2500 JPY

Ordinary

CFD

SHORT

8800

4775.4423 JPY

Ordinary

CFD

SHORT

1600

4775.4423 JPY

Ordinary

CFD

LONG

1000

4806.8000 JPY

Ordinary

CFD

LONG

3300

4697.2727 JPY

Ordinary

CFD

SHORT

140000

4844.0606 JPY

Ordinary

CFD

LONG

3154

4629.7157 JPY

Ordinary

CFD

LONG

50300

4800.1809 JPY

Ordinary

CFD

SHORT

50300

4800.1809 JPY

Ordinary

CFD

LONG

168700

4795.4994 JPY

 

 (c)       Stock-settled derivative transactions (including options)               

 

(i)         Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

 

(ii)        Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A

N/A

N/A

N/A

N/A

 

(d)        Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

N/A

N/A

N/A

 

 

4.         OTHER INFORMATION

 

(a)        Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b)        Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c)        Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

02 AUGUST 2018

Contact name:

Craig Horsley

Telephone number:

+44(141) 245 7736

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk.  The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEOEAEPAEDPPEFF

Recent news on Takeda Pharmaceutical Co

See all news